Osteoblast-specific CGRP receptor -expression of osteoblastic differentiation-independent non-type I CGRP receptor-

成骨细胞特异性 CGRP 受体 -成骨细胞分化独立的非 I 型 CGRP 受体的表达 -

基本信息

  • 批准号:
    16591855
  • 负责人:
  • 金额:
    $ 2.05万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2006
  • 项目状态:
    已结题

项目摘要

1) Effects of CGRP on cytoplasmic Ca^<2+> mobilization and membrane potentialIn human osteoblastic MG63 cells, CGRP (1-100 nM) induced a transient Ca^<2+> spike and a subsequent slow increment in cytoplasmic free Ca^<2+> concentrations ([Ca^<2+>]_i). The second phase was not observed in rat osteoblastic UMR106 cells. CGRP also induced plasma membrane hyperpolarization. This action was attenuated only approximately 50% by an antagonist of CGRP subtype I receptor (CGRP-R1), CGRP_<8-37>. These findings suggest that These CGRP actions are not solely mediated by known CGRP-R1 but also by other non-subtype I receptors.2) Schild plot analysis of CGRP-induced cellular responsesIn MG63 cells, the CGRP-induced cellular responses, such as cAMP production, p38-MAPK phosphorylation, and CREB phosphorylation, were identified to be mediated by the same single CGRP receptor subtype, probably CGRP-R1. In contrast, CGRP-induced ERK dephosphorylation was suggested to be mediated either by a single unknown subtype of CGRP receptor or by a combination of CGRP-R1 and a unknown receptor subtype(s).3) Effects of adrenomedullin, calcitonin, and their specific antagonists on intracellular signaling pathwaysIn addition to MG63 cells, human periodontal ligament cells were employed here. Both adrenomedullin (ADM) and calcitonin (CT) at higher concentrations (1 μM) mimicked CGRP action, but their specific antagonists, such as ADM_<22-52> and CT_<8-32>, failed to significantly block CGRP action. These findings suggest that CGRP actions we have observed are not mediated either by ADM receptor or CT receptor, but by several CGRP-specific receptor subtypes.
1)CGRP OND MEMRBANE势素蛋白成骨细胞MG63细胞,CGRP(1-100 nm)<2+>尖峰和随后的细胞质游离Ca^<2+浓度的慢速增量([Ca^<2+>])。在大鼠成骨细胞UMR106细胞诱导的质体ization中未观察到第二相。由已知的CGRP-R1 E I受体介导的Soly。2)CGRP诱导的细胞反应的Schild图分析MG63细胞,CGRP诱导的Cellaru反应,例如CAMP生产,p38-MAPK磷酸化,由同一单个CGRP介导受体亚型,可能的CGRP-R1。细胞以较高浓度(1μM)的含量使用丁蛋蛋白(ADM)和降钙素(CT),但是它们的特定拮抗剂,例如ADM_ <222-52>和CT_ <8-32>,这些发现表明我们意识到的CGRP动作是不是由ADM受体或CT PTOR介导的,而是由几种CGRP特异性受体亚型介导的。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that differentially respond to [Cys(Acm)^<2, 7>]-CGRP and CGRP_<8-37>.
未成熟的成骨细胞MG63细胞具有两种降钙素基因相关肽受体亚型,它们对[Cys(Acm)^<2, 7>]-CGRP和CGRP_<8-37>有不同的反应。
Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that differentially respond to [Cys(Acm)^<2,7>]-CGRP and CGRP_<8-37>.
未成熟的成骨细胞MG63细胞具有两种降钙素基因相关肽受体亚型,它们对[Cys(Acm)^<2,7>]-CGRP和CGRP_<8-37>有不同的反应。
Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that differentially respond to [Cys(Acm)^<2.7>]-CGRP and CGRP_<8-37>.
未成熟的成骨细胞MG63细胞具有两种降钙素基因相关肽受体亚型,其对[Cys(Acm)^<2.7>]-CGRP和CGRP_<8-37>有不同的反应。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAWASE Tomoyuki其他文献

KAWASE Tomoyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAWASE Tomoyuki', 18)}}的其他基金

Tissue-engineering of cartilage by the use of alveolar bone-derived periosteal sheets
使用牙槽骨来源的骨膜片进行软骨组织工程
  • 批准号:
    24659872
  • 财政年份:
    2012
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Developments of scaffolds and processing technology to maximize the osteogenic potential of cultured periosteal sheets
开发支架和加工技术,最大限度地发挥培养骨膜片的成骨潜力
  • 批准号:
    21592492
  • 财政年份:
    2009
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Three-dimensional high density culture of periodontal ligament cells on porous Hap blocks and their osteogenic induction
多孔Hap块上牙周膜细胞三维高密度培养及其成骨诱导
  • 批准号:
    19592140
  • 财政年份:
    2007
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on CGRP receptor subtypes and their specific intracellular signaling pathways in the periodontal tissue
牙周组织CGRP受体亚型及其特异性细胞内信号通路的研究
  • 批准号:
    12671803
  • 财政年份:
    2000
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

新木姜子碱靶向芳香烃受体调控人羊膜间充质干细胞向成骨细胞定向分化的作用机制研究
  • 批准号:
    22367025
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
成骨细胞雄激素受体通过外泌体VCAN介导应力负载下骨重建的作用机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
钙敏感受体CaSR介导糖基化修饰GP-12肽诱导成骨细胞增殖分化的分子机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
4F2hc受体介导galectin-3所致骨关节炎软骨下骨成骨细胞表型改变及分子机制
  • 批准号:
    82002337
  • 批准年份:
    2020
  • 资助金额:
    24 万元
  • 项目类别:
    青年科学基金项目
NOD2模式识别受体在牙髓卟啉单胞菌外膜囊泡介导骨破坏中的作用机制
  • 批准号:
    81900992
  • 批准年份:
    2019
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The role of osteoblast progenitors in response to bone anabolic agents
成骨细胞祖细胞对骨合成代谢剂的反应的作用
  • 批准号:
    10404415
  • 财政年份:
    2023
  • 资助金额:
    $ 2.05万
  • 项目类别:
How bisphosphonates affect bone matrix and remodeling: implications for atypical femoral fractures
双磷酸盐如何影响骨基质和重塑:对非典型股骨骨折的影响
  • 批准号:
    10586949
  • 财政年份:
    2023
  • 资助金额:
    $ 2.05万
  • 项目类别:
Mechanistic investigation into Frizzled-2 signaling for treatment of Osteogenesis Imperfecta
Frizzled-2 信号传导治疗成骨不全症的机制研究
  • 批准号:
    10680236
  • 财政年份:
    2023
  • 资助金额:
    $ 2.05万
  • 项目类别:
next-generation sequencing approaches to identify genotype-phenotype relationships during miRNA tuning of neural crest osteogenesis
新一代测序方法可识别神经嵴成骨过程中 miRNA 调节过程中的基因型与表型关系
  • 批准号:
    10579800
  • 财政年份:
    2023
  • 资助金额:
    $ 2.05万
  • 项目类别:
Characterization of PDGFR alpha/beta heterodimers
PDGFR α/β 异二聚体的表征
  • 批准号:
    10676610
  • 财政年份:
    2023
  • 资助金额:
    $ 2.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了